financetom
Business
financetom
/
Business
/
Biogen Closes Human Immunology Biosciences Acquisition
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Biogen Closes Human Immunology Biosciences Acquisition
Jul 2, 2024 7:34 AM

10:25 AM EDT, 07/02/2024 (MT Newswires) -- Biogen (BIIB) said Tuesday it has completed the acquisition of privately-held clinical-stage biotechnology firm Human Immunology Biosciences.

Financial details were not disclosed.

Biogen stock was down 0.8% in recent trading.

Price: 229.75, Change: -2.03, Percent Change: -0.87

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved